These data demonstrate that miR-590-3p nanomiRs robustly inhibit multiple oncogenic nodes downstream of TGFBR2 to achieve robust anti-tumor effects in an orthotopic mouse model of human rGBM. The gene discussed is TGFBR2; the disease is neoplasm.